The Jardiance Resubmission Journey: From FDA CRL to Approval
Hello Regulatory Scientists, Today, let’s explore the journey of Jardiance (empagliflozin) from receiving an FDA Complete Response Letter (CRL) to achieving approval. This case study provides valuable insights and lessons that can guide companies developing new drugs today. Regulatory History and Initial Submission Drug: Jardiance (empagliflozin) Mechanism of Action: Sodium-glucose co-transporter 2 (SGLT2) inhibitor, which […]
The Heartfelt Journey with Advanced Tissue Products
Introduction:In the intricate tapestry of healthcare, hope often comes in unexpected forms. Advanced Tissue Products stand as a testament to the compassion and innovation that weave together to redefine the healing journey. Join us on a heartfelt exploration of the profound impact these cutting-edge marvels are having on the lives of individuals, offering not just […]